- Home
- ZURA vs PDSB Comparison
ZURA vs PDSB Comparison
Compare ZURA & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- PDSB
- Stock Information
- Founded
- ZURA 2022
- PDSB 2005
- Country
- ZURA United States
- PDSB United States
- Employees
- ZURA N/A
- PDSB N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- ZURA Health Care
- PDSB Health Care
- Exchange
- ZURA Nasdaq
- PDSB Nasdaq
- Market Cap
- ZURA 69.9M
- PDSB 72.2M
- IPO Year
- ZURA N/A
- PDSB N/A
- Fundamental
- Price
- ZURA $1.30
- PDSB $1.17
- Analyst Decision
- ZURA Buy
- PDSB Strong Buy
- Analyst Count
- ZURA 7
- PDSB 2
- Target Price
- ZURA $14.33
- PDSB $10.00
- AVG Volume (30 Days)
- ZURA 689.3K
- PDSB 467.6K
- Earning Date
- ZURA 08-08-2025
- PDSB 08-12-2025
- Dividend Yield
- ZURA N/A
- PDSB N/A
- EPS Growth
- ZURA N/A
- PDSB N/A
- EPS
- ZURA N/A
- PDSB N/A
- Revenue
- ZURA N/A
- PDSB N/A
- Revenue This Year
- ZURA N/A
- PDSB N/A
- Revenue Next Year
- ZURA N/A
- PDSB N/A
- P/E Ratio
- ZURA N/A
- PDSB N/A
- Revenue Growth
- ZURA N/A
- PDSB N/A
- 52 Week Low
- ZURA $0.97
- PDSB $0.85
- 52 Week High
- ZURA $5.07
- PDSB $4.42
- Technical
- Relative Strength Index (RSI)
- ZURA 58.73
- PDSB 35.94
- Support Level
- ZURA $1.00
- PDSB $1.20
- Resistance Level
- ZURA $1.45
- PDSB $1.40
- Average True Range (ATR)
- ZURA 0.10
- PDSB 0.10
- MACD
- ZURA 0.02
- PDSB -0.02
- Stochastic Oscillator
- ZURA 66.67
- PDSB 4.26
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.